Donor T cells for CAR T cell therapy

Adoptive cell therapy using patient-derived chimeric receptor antigen (CAR) T cells redirected against tumor cells has shown remarkable success in treating hematologic cancers. However, wider accessibility of cellular therapies for all patients is needed. Manufacture of patient-derived CAR T cells i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Tiffany C. Y., Xu, Ning, Nordon, Robert, Haber, Michelle, Micklethwaite, Kenneth, Dolnikov, Alla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973942/
https://www.ncbi.nlm.nih.gov/pubmed/35365224
http://dx.doi.org/10.1186/s40364-022-00359-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973942/
https://www.ncbi.nlm.nih.gov/pubmed/35365224
http://dx.doi.org/10.1186/s40364-022-00359-3

Ejemplares similares